Bellevue Group Ag Beam Therapeutics Inc. Transaction History

Bellevue Group Ag

$4.67 Billion
Q3 2025

A detailed history of Bellevue Group Ag transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 2,889,288 shares of BEAM stock, worth $63.6 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares

2,889,288

Previous 2,889,288 -0.0%

Holding current value

$63.6 Million

Previous $49.1 Million 42.68%

% of portfolio

1.5%

Previous 1.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$14.54 - $20.24 $7.17 Million - $9.99 Million	493,358 Added 20.59%	2,889,288 $49.1 Million
Q1 2025 May 14, 2025	BUY	$19.53 - $34.09 $17.1 Million - $29.9 Million	877,809 Added 57.82%	2,395,930 $46.8 Million
Q3 2024 Nov 14, 2024	BUY	$22.57 - $33.14 $2.26 Million - $3.31 Million	100,000 Added 7.05%	1,518,121 $37.2 Million
Q2 2024 Aug 14, 2024	BUY	$21.22 - $32.66 $4.77 Million - $7.35 Million	225,000 Added 18.86%	1,418,121 $33.2 Million
Q1 2024 May 15, 2024	BUY	$23.46 - $45.07 $11.7 Million - $22.5 Million	498,300 Added 71.72%	1,193,121 $39.4 Million

Q3 2023 Nov 14, 2023	SELL	$23.01 - $32.46 $13,806 - $19,476	-600 Reduced 0.09%	694,821 $16.7 Million
Q1 2023 May 15, 2023	SELL	$30.15 - $48.79 $39,195 - $63,427	-1,300 Reduced 0.19%	695,421 $21.3 Million
Q4 2022 Feb 14, 2023	BUY	$36.73 - $51.6 $4.59 Million - $6.45 Million	125,000 Added 21.86%	696,721 $27.2 Million
Q3 2022 Nov 14, 2022	SELL	$39.79 - $70.31 $35,811 - $63,279	-900 Reduced 0.16%	571,721 $27.2 Million
Q2 2022 Aug 11, 2022	SELL	$29.86 - $62.36 $304,572 - $636,072	-10,200 Reduced 1.75%	572,621 $22.2 Million
Q1 2022 May 13, 2022	SELL	$53.73 - $82.16 $1.61 Million - $2.46 Million	-30,000 Reduced 4.9%	582,821 $33.4 Million
Q2 2021 Aug 12, 2021	BUY	$64.12 - $128.71 $2.95 Million - $5.92 Million	46,000 Added 8.12%	612,821 $78.9 Million
Q1 2021 May 12, 2021	BUY	$71.28 - $120.75 $12.1 Million - $20.5 Million	170,000 Added 42.84%	566,821 $45.4 Million
Q4 2020 Feb 16, 2021	BUY	$22.24 - $95.63 $8.83 Million - $37.9 Million	396,821 New	396,821 $32.4 Million

Others Institutions Holding BEAM

# of Institutions

249

Shares Held

95M

Call Options Held

888K

Put Options Held

549K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.55B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Beam Therapeutics Inc. Transaction History